estimate the total number of IDU in Edinburgh over the period [1992] [1993] [1994] .
The study was undertaken in order to obtain two estimates: the number of HIV-infected IDU alive in Edinburgh, and the total number of currently injecting IDU. These are the first such estimates for the city. They provide baseline data against which it will be possible to assess the efficacy of measures to reduce the spread of HIV between IDU.
Methods

Number of infected IDU
The number of HIV-infected individuals who said they had ever injected drugs and who had had a named HIV test before the end of 1994 was obtained from the Lothian HIV Register. This contains the results of all named antibody tests performed in the region since the beginning of the epidemic. The register includes non-attributable identifiers (first and last initials, sex, and date of birth), lists the postal area of residence, and notes whether individuals are alive or have died. Postcode data were missing from some injectors and, because of loss to follow-up, it was not known whether some were still alive. Maximum and minimum estimates based on the register either included or excluded ever injectors from whom some data were missing. An intermediate figure was estimated by allocating individuals with missing data in the same proportions as those whose status was known. To correct for the minority of HIV-infected injectors who were not on the register, the estimates were divided by the proportion found in the city-wide survey of HIV prevalence to be infected and who had had positive named antibody tests at any time before being interviewed for the survey.
Prevalence of HIV in IDU
The prevalence of HIV infection was obtained from the study of antibody prevalence in Edinburgh drug users. During the 3 years 1992-1994, Edinburgh residents who had injected at least once in the previous 6 months (current injectors) were interviewed in a city-wide cross-sectional survey in which they were asked for a sample of saliva which was examined for antibodies to HIV. 6 In the last 2 years of the study, current oral users who had injected but not in the 6 months before interview (former injectors), were also recruited. In the final year, current oral users, who had taken drugs more than once a week on average during the previous 6 months but said they had never injected, were included. The interviews and saliva tests were anonymous. However, as in the HIV register, non-attributable identifiers were recorded. These permitted elimination of duplicate interviews and comparison with other lists of IDU.
Number of IDU
The number of users who had ever injected was estimated in two ways, one based on the HIV register, the other by capturerecapture methodology.
HIV register method
The HIV prevalence, p, among ever-injectors was estimated directly as the proportion, p = H/S, of the S ever injectors recruited into the city-wide survey, H of whom tested positive. The total number, N, of ever injectors known to be alive and resident in Edinburgh was then estimated as the number, Z, of ever injectors on the HIV register, divided by p multiplied by the proportion, h, of HIV-infected injectors in the survey who were recorded on the register: N = Z/(p * h). This estimate was then scaled up to allow for those of unknown current residence or life status (Appendix).
However, both the number on the register and the HIV prevalence among drug injectors were strongly age-and sexrelated, and the age distributions of the register and the survey were different. Thus N was estimated separately for each sex and for each year-of-age class for those aged у25. Because of the small number of injectors in each class, H was often small or zero. To reduce the resulting irregularity in N, smoothed values of S were used, calculated as:
where t was the year of age. Smoothed values of H and Z were obtained in the same way.
At ages Ͼ40, smoothing over a wider age-class was necessary, and was possible because p did not appear to change with age in this group, so that the estimate of population size for either sex changed little as age-classes were amalgamated. However, smoothing was unable to adjust for the absence of HIV among those Ͻ20 both in the survey and on the register, or for the low and variable prevalence among those Ͻ25, many of whom the survey found to be ever injectors. Estimates of the number of young injectors by this method necessitated extrapolation from the estimates of older IDU. Therefore the totals of the estimates of N in older year-classes were scaled up by a factor derived from the age distribution of survey respondents. The proportion of current injectors was based on the ratio of current to ever injectors recruited in the last 2 years of the city-wide survey.
Log-linear method
The second method used the city-wide survey sample in conjunction with three other lists of ever injectors. 7 These recorded attendance at the Edinburgh Community Drug Problem Service, non-statutory drug agencies, and family doctors' surgeries. For this analysis the survey list was reduced to those not directly recruited to the survey via agencies contributing to other lists. Counts were stratified by sex and by age, the latter into either two (р27 years, у28) or three (р24, 25-29, у30) equally-sized classes. This allowed recombination of the two older classes to facilitate comparison between the methods. Models of independence, of heterogeneity, and allowing different dependencies between all or some pairs of lists, were analysed. Selection of a single best, parsimonious model would have been technically questionable, particularly for the Ͻ25s, who provided few listings. 8 Estimates quoted are from the model including all two-list interactions, which incorporates some degree of heterogeneity between individuals and more direct dependence between lists.
Prevalence of injecting drug use
Estimates of the prevalence of injecting, by age and by sex, were made by applying the age-sex distribution of current injectors recruited into the city-wide survey to the intermediate estimate of the number of current injectors derived from the HIV register. These figures were then divided by the number of people in Edinburgh in each age and sex band according to the 1991 census. 9 
Confidence intervals
Except for estimates of the number of IDU, confidence limits (CI) were estimated using the formula for binomial distributions:
where p was the proportion infected, z′ the percentage point of the normal distribution, and n the total number. Approximate limits were obtained for the HIV register-based estimate of IDU, making the standard assumption that N was normally distributed:
with variance given by:
As Z was a count, Z* was taken to be a Poisson variable, so that var(Z*) was estimated by Z*. p* and h* were binomial proportions so their variances were p*(1 -p*)/n and h*(1 -h*)/n. The variance of N was estimated for each age stratum and the values were summed. Interval estimates for the log-linear mark-recapture estimates in each age-sex stratum were obtained by profile likelihood, 10 assuming the selected model to be true. Relaxation of this assumption would widen them.
Results
Number of infected IDU
The HIV register listed 371 HIV-infected drug users who had ever injected and were known to be alive and resident in Edinburgh (Table 1) . Some 198 resided outside Edinburgh or had died. Data on residence or whether the subject was alive at any time during the 3-year study period were missing for 179. Partitioning suggested that some 77 of the latter were alive and resident in Edinburgh. This number was added to the minimum estimate from the register to give an intermediate estimate of 448. In the city-wide survey, 95.0% of HIV-infected respondents had had named antibody tests previously and were therefore on the register. To allow for those not on the register, 448 was divided by this proportion, giving 472.
Prevalence of HIV
In the city-wide survey, saliva HIV antibody tests showed the percentages of the different groups of user to be infected (Table 2) . Of ever injectors 92% had lived in Edinburgh for у5 years, and 87% for у10 years.
Number of IDU
HIV register method Aggregation of the age-class estimates of male ever injectors aged у25 gave a smoothed total of 1010 (Table 3 ). This figure was divided by 0.95 to correct for those who had not had named HIV tests, multiplied by 1.2 to allow for those from whom data Oral users who had never injected 182 0.5 (0.0-1.0) a The deviance is a measure of lack of fit between data and the log-linear model with all two-list interactions, to be assessed against a χ 2 distribution with four degrees of freedom. Thus each of these cases shows a reasonable fit. b Calculated from the proportion of survey respondents who had injected at least once in the previous 6 months. about residence or being alive were missing, and by 1.53 to include those Ͻ25. This gave 1950 male injectors. The corresponding figures for females were 660, with factors of 0.95, 1.2 and 1.66, giving a final estimated total of 1380. Thus taking the sexes together the numbers of Edinburgh ever and current injectors were about 3330 and 1670.
All the confidence intervals in Table 2 are rough approximations, based on assumptions of normality, and with variances calculated by Taylor series approximations applied to functions of observed binomial proportions. 11 Since some minor sources of variation have been ignored, and the distributional assumptions are dubious, the quoted intervals are likely to underestimate the true uncertainty.
Log-linear method
In all, 1147 Edinburgh-resident drug users who had ever injected consulted their family doctors because of drug use (D), attended the Community Drug Problem Service (C), or local drug agencies (L), or were recruited into the HIV prevalence study (H). The numbers in one or more of these four samples were: C 287, D 94, H 336, L 167, CD 38, CH 67, CL 18, DH 33, DL 9, HL 51, CDH 15, CDL 2, CHL 14, DHL 9, and CDHL 7. In log-linear analyses, independence and heterogeneity models were inadequate for some strata, whereas a model allowing all two-list dependencies provided a good fit to all strata except for the males Ͻ25 and females Ͻ28. Patterns of estimates of list inclusion probabilities were sufficiently close for separate ages within each sex to permit an aggregated analysis with this model for each sex (Table 3) . These indicated a total of about 3900 ever injectors, and thus about 2070 current injectors.
Prevalence of injecting
The log-linear estimate of the number of current injectors gave an overall prevalence of injecting of 8.0 per 1000 Edinburgh residents aged 15-59 years (Table 4) . For the intermediate HIV register-based method the figure was 6.9 per 1000 (95% CI : 5.2-8.7). In the city-wide survey, current injectors reported injecting over a median period of 8 years. Thus these 3-year period figures should be reduced by a factor of 1 -(7/8) 2 , or roughly a quarter, to give one-year estimates. Injecting was most prevalent in the 20-29 year age group, and males were two and a half times more likely to inject than females.
Discussion
The prevalence of current injecting drug use was estimated by two different methods to be 8.0 and 6.9 per 1000 Edinburgh residents aged 15-59 years. The estimated number of HIVinfected ever injectors in the city was 472. HIV antibody prevalence in those who had ever injected was 17.7%, compared with only 0.5% in oral users who had never injected. The long period for which most of the sample had lived in Edinburgh indicated that the population was relatively stable. The lists used to calculate the number of ever injectors by the log-linear method contained those who were current drug users but not those whose drug taking careers were over or in abeyance. This would lead the method to underestimate the number of ever injectors, but not the number of current injectors as this was calculated from the ratio of current to ever injectors recruited in the last 2 years of the survey. For the same reason, the HIV register derived number of current injectors would tend to be an overestimate.
Estimation of the size of the hidden part of a population by log-linear analysis is most reliable when the intersecting lists are independent random samples, which none of our lists were. Though the city-wide survey provided the most representative sample, it was not a truly random one. Young people who had recently started injecting and ill users tending to keep to their homes were probably under-represented in it and in the two agency samples, whereas ill users are likely to have been overrepresented in the family doctor sample. When lists sample different populations, there are analytical and interpretational problems. In analysis, interactions of all orders are likely to be generated and even their signs may be uncertain. Furthermore, it is not known which population is being estimated. Because it is likely that subgroups of IDU did not have an equal chance of appearing in all lists, the log-linear method may have overestimated the number of users who had ever injected. Unfortunately the agency and family doctor samples contained only minorities of the users attending these services, thereby reducing the precision of the log-linear analysis.
Estimation of population size from the overlaps between lists is very uncertain. No simple rules can be given for the sizes of sample needed for reliability, since the information available about the population size depends heavily also on the degree of heterogeneity among individuals and on the statistical patterns of dependence between lists. Here the model with all two-list interactions fits well the totality of all individuals, the totality of males and, with some different capture probabilities (particularly for List C and its interaction with List L), the totality of females. Each of the interactions is significant in at least one age-sex stratum. Despite this statistical fit, the model is unlikely to represent all aspects of the lists, because of its lack of fit to some subgroups (Results section) and because of limited statistical power against any more complex statistical model, particularly for females. In consequence the wide interval estimates given here may not be wide enough.
The high proportion of HIV-positive survey respondents who had been tested previously suggests that the HIV register contained records of nearly all infected drug users. If some of the previous antibody tests had been done outside Edinburgh, the register-derived estimates would be lower than they should be. Such an effect is likely to be small because of the stability of the population. A major problem for the register-based method of estimating the number of injectors was that few Ͻ25 were infected with HIV. It was therefore necessary to extrapolate from the number of older users so as to include the whole age range. For this reason we place more reliance on the log-linear method.
In Edinburgh, the prevalence of injecting in the 2 months before interview was less than half that found in Glasgow in 1990 (5.0 versus 13.5/1000). 12 As in Glasgow, the prevalence was higher in males and was concentrated in the 20-29 year age group. In Glasgow only 1% of currently injecting drug users was infected with HIV. The paradox of a higher prevalence of HIV in Edinburgh injectors in spite of the higher prevalence of injecting in Glasgow has still to be fully explained. In Edinburgh the proportion of drug users who injected used to be greater than it now is, and awareness of the high prevalence of HIV in Edinburgh IDU has probably deterred injecting in this city. 13 A misconceived policy of preventing users from having access to new injecting equipment in Edinburgh in the mid-1980s favoured spread of HIV, whereas the early development of effective needle exchange facilities in Glasgow reduced the risk of transmission. 6, 12 In both cities, counselling against high risk activities and the prescribing of oral opioids have been important strategies to counter spread of the virus. It is not known whether genetic differences in the virus may have resulted in differences in virulence or infectivity between the two cities. In spite of the larger population of Glasgow and the higher prevalence of injecting there, the estimated number of HIV-infected current injectors in Edinburgh is about twice that in Glasgow.
These estimates of injecting prevalence and of the number of HIV-infected IDU are important baseline statistics for monitoring the efficacy of measures aimed at reducing transmission of HIV amongst drug users and for the planning of services for infected and uninfected users. Though injecting drug use appears to have diminished in Edinburgh in recent years, there is still a clear need for continuance of measures to reduce injecting further.
